Recombinant Lassa Fever Virus GP2 glycoprotein (Fc Chimera)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Lassa Fever Virus GP2 glycoprotein (Fc Chimera) is a Lassa virus GA391 Fragment protein, in the 259 to 426 aa range, expressed in HEK 293 cells, with >95%, suitable for SDS-PAGE.
View Alternative Names
GP-C, GPC, Pre-glycoprotein polyprotein GP complex, Pre-GP-C
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Lassa Fever Virus GP2 glycoprotein (Fc Chimera) (AB256440)
SDS-PAGE analysis of ab256440 (10 μg) under reducing conditions.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The GP complex is involved in the encapsulation of the viral RNA aiding the virus to evade the host immune response. It functions as part of a larger assembly known as the viral envelope complex. By promoting fusion between the viral membrane and the host's cellular membrane GP enables the viral genome to enter the host cell. This fusion facilitates the infection process and contributes to the viral pathogenicity. Its role in immune evasion involves forming a protective shield by cloaking the receptor-binding sites challenging the host's immune surveillance mechanisms.
Pathways
The GP complex influences the viral entry pathway which is an important step in the infection process for viral replication. It also interacts closely with the NPC1 receptor pathway in humans an important receptor for Ebola virus entry. The interaction with NPC1 a protein that traffics cholesterol in cells is essential for the virus's entry into the host cell endosome where the viral and endosomal membranes fuse. Another protein related through this pathway is the cathepsin family which processes the GP complex to enable effective fusion.
Specifications
Form
Liquid
General info
Function
Stable signal peptide. Functions as a cleaved signal peptide that is retained as the third component of the GP complex (GP-C). Helps to stabilize the spike complex in its native conformation. The SSP is required for efficient glycoprotein expression, post-translational maturation cleavage of G1 and G2, glycoprotein transport to the cell surface plasma membrane, formation of infectious virus particles, and acid pH-dependent glycoprotein-mediated cell fusion.. Glycoprotein G1. Forms the virion spikes together with glycoprotein G2. The glycoprotein spike trimers are connected to the underlying matrix. Interacts with the host receptor. Mediates virus attachment to the host primary receptor alpha-dystroglycan DAG1 (alpha-DG) at the cell surface. This attachment induces virion internalization apparently through macropinocytosis. Following endocytosis, there is a pH-dependent switch from binding DAG1 to the host lysosomal receptor LAMP1. This latter binding triggers the dissociation of GP1, exposing the fusion subunit, GP2, such that fusion can occur. Down-modulates host DAG1.. Glycoprotein G2. Forms the virion spikes together with glycoprotein G1. The glycoprotein spike trimers are connected to the underlying matrix. Class I viral fusion protein that directs fusion of viral and host endosomal membranes, leading to delivery of the nucleocapsid into the cytoplasm. Membrane fusion is mediated by irreversible conformational changes induced by acidification.
Sequence similarities
Belongs to the arenaviridae GPC protein family.
Post-translational modifications
Pre-glycoprotein polyprotein GP complex. Specific enzymatic cleavages in vivo yield mature proteins. GP-C polyprotein is cleaved in the endoplasmic reticulum by the host protease MBTPS1. Only cleaved glycoprotein is incorporated into virions. The SSP remains stably associated with the GP complex following cleavage by signal peptidase.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com